Skip to main content
OpenTrials

Clinical trial condition

Vascular Diseases

Explore clinical trials studying Vascular Diseases. Study availability and eligibility vary by location and protocol.

32,623 public trials 5,368 recruiting studies
Refine in advanced search Browse all conditions

Vascular Diseases trial results

Recruiting

Pemafibrate for Symptomatic ICAS RCT

NCT07562178

Conditions
Brain Diseases, Cardiovascular Diseases, Central Nervous System Diseases, +13 more
Locations
  • Iwate Medical University Hospital Hizume, Iwate, Japan
  • Kagoshima Medical Center Kagoshima, Kagoshima-ken, Japan
  • Kumamoto University Hospital Kumamoto, Japan
  • Japanese Red Cross Kyoto Daini Hospital Kyoto, Japan
View all 37 locations
View Trial Details
Recruiting

A Study of the Efficacy and Safety of BCD-248 in Combination With Daratumumab in Patients With Relapsed or Refractory Multiple Myeloma (AMMADINA)

NCT07742215

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • SI "Republican Scientific and Practical Center for Radiation Medicine and Human Ecology" Homyel, Belarus
  • SBHI "Chelyabinsk regional clinical hospital" Chelyabinsk, Russia
  • SBHI "Regional oncological dispensary" Irkutsk, Russia
  • SAHI "Republican Clinical Oncology Dispensary of the Ministry of Health of the Republic of Tatarstan named after Professor M.Z. Sigal" Kazan', Russia
View all 16 locations
View Trial Details
Recruiting

Health for Hungary (H4H) - Longitudinal Collection of Blood Samples and Corresponding Data

NCT07743021

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +51 more
Locations
  • 04_DRC Balatonfüred_Drug Research Center LLC Balatonfüred, Hungary
  • 14_TP Békéscsaba_Trial Pharma LLC Békéscsaba Békéscsaba, Hungary
  • 31_TP Szt Magdolna_Trial Pharma Ltd. Magdalene Private Hospital Budapest, Hungary
  • 08_Qualiclinic Budapest_Qualiclinic LLC Budapest, Hungary
View all 33 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events

NCT07448038

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +2 more
Locations
  • Cardiovascular Research Foundation of Southern California Beverly Hills, California, United States
  • National Heart Institute Beverly Hills, California, United States
  • Amnova Clinical Research Irvine, California, United States
  • Alliance Clinical West Hills (Focus Clinical Research) West Hills, California, United States
View all 16 locations
View Trial Details
Recruiting

A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events

NCT06500884

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Yale University School Of Medicine New Haven, Connecticut, United States
  • Icahn School of Medicine at Mt. Sinai New York, United States
View all 38 locations
View Trial Details
Recruiting

A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide or in Combination With Pomalidomide for Multiple Myeloma

NCT06768489

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Monash Medical Centre Clayton, Australia
  • St Vincents Hospital Melbourne Fitzroy, Australia
  • Peter MacCallum Cancer Centre Melbourne, Australia
  • Calvary Mater Newcastle Hospital Waratah, Australia
View all 16 locations
View Trial Details

Related conditions